• Gehad A. Abdel Jaleel
  • Dalia O. Saleh
  • Sally A. El Awdan Pharmacology department, National Research Centre, Egypt, Pathology department, National Research Centre, Egypt.
  • Manal Badawi


Monascus purpureus, Diabetes, Pioglitazone, Liver, Streptozocin


Objective: Diabetes induces many complications such as cardiovascular problems, cataracts, kidney damage and polyneuropathy. Streptozotocin (STZ) induced diabetes is considered one of the most common animal models in rats. The present study investigated the effects of Monascus purpureus (MP) alone or in combination with pioglitazone on glucose level and on liver in streptozotocin (STZ) diabetic rats.

Methods: In this study were divided into five experimental groups (normal, untreated STZ-diabetic (60 mg/kg B.W., IP), treated STZ-diabetic with Monascus purpureus (500 mg/kg B. W, oral), treated STZ-diabetic with pioglitazone (10 mg/kg B.W., oral) and treated STZ-diabetic with MP (250 mg/kg B. W, oral)+pioglitazone (10 mg/kg B.W., oral)). Treatment continued for 14 d then blood sampling was done to assess blood glucose. At the end of the study, the animals were fasted overnight, anesthetized with sodium pentobarbital (60 mg/kg i.p.), and sacrificed to collect tissues samples (liver, pancreases).

Results: Throughout the experimental period, all treatments significantly (P<.05) lowered serum glucose, triglycerides, cholesterol, c-peptide and IL-6. In addition, hepatic cholesterol and triglycerides levels were also lowered. Moreover, the treated diabetic rats showed higher activity of reduced glutathione (P<.05) in the liver compared with the diabetic control rats and inhibited diabetes induced elevation in the level of malondialdehyde in liver.

Conclusion: The results of this study clearly demonstrated that MP act by many ways, including anti-hyperglycemic, antioxidant effects and pancreatic β-cell protection. From these points, it seems that MP may be a useful supplement to alleviate the development of diabetes and its complications.


Download data is not yet available.


Sellamuthu PS, Arulselvan P, Fakurazi S, Kandasamy M. Beneficial effects of mangiferin isolated from Salacia chinensis on biochemical and hematological parameters in rats with streptozotocin-induced diabetes. Pak J Pharm Sci 2014;27:161-7.

Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994;331:1428-36.

Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 2009;5:219-26.

Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010;107:1058-70.

Kajimoto Y, Kaneto H. Role of oxidative stress in pancreatic beta-cell dysfunction. Ann N Y Acad Sci 2004;1011:168-76.

Ghazanfar K, Ganai BA, Akbar S, Mubashir K, Dar SA, Dar MY, et al. Antidiabetic activity of Artemisia amygdalina decne in streptozotocin induced diabetic rats. Biomed Res Int 2014;18:56-6.

Kannel WB. Lipids, diabetes, and coronary heart disease: insights from the framingham study. Am Heart J 1985;110:1100-7.

Sharma BR, Rhyu DY. Anti-diabetic effects of Caulerpa lentillifera: stimulation of insulin secretion in pancreatic beta-cells and enhancement of glucose uptake in adipocytes. Asian Pac J Trop Biomed 2014;4:575-80.

Johnson DB, Gerstein DE, Evans AE, Woodward-Lopez G. Preventing obesity: a life cycle perspective. J Acad Nutr Diet 2006;106:97-102.

Cheng AY, Fantus IG. Oral antihyperglycemic therapy for type 2 diabetes mellitus. Can Med Assoc J 2005;172:213-26.

Waugh J, Keating GM, Plosker GL, Easthope S, Robinson DM. Pioglitazone: a review of its use in type 2 diabetes mellitus. Drugs 2006;66:85-109.

Choi SY, Noh MR, Kim DK, Sun W, Kim H. Neuroprotective function of thymosin-beta and its derivative peptides on the programmed cell death of chick and rat neurons. Biochem Biophys Res Commun 2007;362:587-93.

Dominguez CM. Diabetes, the americans with disabilities act, and the eeoc. Diabetes Forecast 2003;56:66-8.

Erdogrul O, Covaci A, Kurtul N, Schepens P. Levels of organohalogenated persistent pollutants in human milk from kahramanmaras region, turkey. Environ Int 2004;30:659-66.

Li YG, Zhang F, Wang ZT, Hu ZB. Identification and chemical profiling of monacolins in red yeast rice using high-performance liquid chromatography with photodiode array detector and mass spectrometry. J Pharm Biomed Anal 2004;35:1101-12.

Liu J, Zhang J, Shi Y, Grimsgaard S, Alraek T, Fonnebo V. Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials. Chin Med 2006;1:4.

Brosky G, Logothetopoulos J. Streptozotocin diabetes in the mouse and guinea pig. Diabetes 1969;18:606-11.

Trinder P. Determination of blood glucose using 4-amino phenazone as oxygen acceptor. J Clin Pathol 1969;22:246.

Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982;28:2077-80.

Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.

Judzewitsch RG, Pfeifer MA, Best JD, Beard JC, Halter JB, Porte D Jr. Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose. J Clin Endocrinol Metab 1982;55:321-8.

Shi YC, Liao JW, Pan TM. Antihypertriglyceridemic and anti-inflammatory activities of Monascus-fermented dioscorea in streptozotocin-induced diabetic rats. J Diabetes Res 2011. Doi.org/10.1155/2011/710635. [Article in Press]

Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978;86:271-8.

Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963;61:882-8.

Hamilton PW, Allen DC. Morphometry in histopathology. J Pathol 1995;175:369-79.

Ivorra MD, Paya M, Villar A. A review of natural products and plants as potential antidiabetic drugs. J Ethnopharmacol 1989;27:243-75.

Larsen MO, Wilken M, Gotfredsen CF, Carr RD, Svendsen O, Rolin B. Mild streptozotocin diabetes in the gottingen minipig. A novel model of moderate insulin deficiency and diabetes. Am J Physiol Endocrinol Metab 2002;282:E1342-51.

Ozturk Y, Altan VM, Yildizoglu-Ari N. Effects of experimental diabetes and insulin on smooth muscle functions. Pharmacol Rev 1996;48:69-112.

Noda Y, Kneyuki T, Igarashi K, Mori A, Packer L. Antioxidant activity of nasunin, an anthocyanin in eggplant peels. Toxicol 2000;148:119-23.

Junod A, Lambert AE, Orci L, Pictet R, Gonet AE, Renold AE. Studies of the diabetogenic action of streptozotocin. Proc Soc Exp Biol Med 1967;126:201-5.

Rerup CC. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev 1970;22:485-518.

Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia 2000;43:1528-33.

Solanki ND, Bhavsar SK. An evaluation of the protective role of Ficus racemosa linn. in streptozotocin-induced diabetic neuropathy with neurodegeneration. Indian J Pharmacol 2015;47:610-5.

Tunali S, Yanardag R. Effect of vanadyl sulfate on the status of lipid parameters and on stomach and spleen tissues of streptozotocin-induced diabetic rats. Pharmacol Res 2006;53:271-7.

Soon YY, Tan BK. Evaluation of the hypoglycemic and anti-oxidant activities of Morinda officinalis in streptozotocin-induced diabetic rats. Singapore Med J 2002;43:77-85.

Ktari N, Mnafgui K, Nasri R, Hamden K, Bkhairia I, Ben Hadj A, et al. Hypoglycemic and hypolipidemic effects of protein hydrolysates from zebra blenny (Salaria basilisca) in alloxan-induced diabetic rats. Food Funct 2013;4:1691-9.

Krishnakumar K, Augusti KT, Vijayammal PL. Anti-peroxidative and hypoglycaemic activity of Salacia oblonga extract in diabetic rats. Pharm Biol 2000;38:101-5.

Sethupathy S, Elanchezhiyan C, Vasudevan K, Rajagopal G. Antiatherogenic effect of taurine in high fat diet fed rats. Indian J Exp Biol 2002;40:1169-72.

Frayn KN, Coppack SW, Humphreys SM, Clark ML, Evans RD. Periprandial regulation of lipid metabolism in insulin-treated diabetes mellitus. Metab Clin Exp 1993;42:504-10.

Saravanan G, Ponmurugan P. S-allylcysteine improves streptozotocin-induced alterations of blood glucose, liver cytochrome p450 2e1, plasma antioxidant system, and adipocytes hormones in diabetic rats. Int J Endocrinol Metab 2013;11:e10927. Doi:10.5812/ijem.10927. [Article in Press]

Patel MB, Mishra SH. Hypoglycemic activity of c-glycosyl flavonoid from Enicostemma hyssopifolium. Pharm Biol 2011;49:383-91.

Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro-and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 2011;1813:878-88.

Kumar G, Murugesan AG. Hypolipidaemic activity of Helicteres isora l. Bark extracts in streptozotocin induced diabetic rats. J Ethnopharmacol 2008;116:161-6.

Menendez JA, Colomer R, Lupu R. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to nwankwo's hypothesis. Med Hypotheses 2005;64:337-41.

Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405-12.

Ewis SA, Abdel-Rahman MS. Effect of metformin on glutathione and magnesium in normal and streptozotocin-induced diabetic rats. J Appl Toxicol 1995;15:387-90.

Winterbourn CC, Metodiewa D. Reaction of superoxide with glutathione and other thiols. Method Enzymol 1995;251:81-6.

Loven D, Schedl H, Wilson H, Daabees TT, Stegink LD, Diekus M, et al. Effect of insulin and oral glutathione on glutathione levels and superoxide dismutase activities in organs of rats with streptozocin-induced diabetes. Diabetes 1986;35:503-7.

Maritim AC, Sanders RA, Watkins JB. 3rd: Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003;17:24-38.

Gutteridge JM. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995;41:1819-28.

Erejuwa OO, Gurtu S, Sulaiman SA, Ab Wahab MS, Sirajudeen KN, Salleh MS. Hypoglycemic and antioxidant effects of honey supplementation in streptozotocin-induced diabetic rats. Int J Vitam Nutr Res 2010;80:74-82.

Kakkar R, Mantha SV, Radhi J, Prasad K, Kalra J. Antioxidant defense system in diabetic kidney: a time course study. Life Sci 1997;60:667-79.



How to Cite

Jaleel, G. A. A., D. O. Saleh, S. A. E. Awdan, and M. Badawi. “HEPATOPROTECTIVE ACTIVITY OF MONASCUS PURPUREUS (RED RICE YEAST) IN DIABETIC RATS ALONE OR IN COMBINATION WITH PIOGLITAZONE: AN EFFECT MEDIATED THROUGH CYTOKINES, ANTIOXIDANTS AND LIPID BIOMARKERS”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 8, no. 8, Aug. 2016, pp. 107-14, https://www.innovareacademics.in/journals/index.php/ijpps/article/view/11778.



Original Article(s)